This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Torres, O. A. Articles by Hyland, K. Search for Related Content PubMed PubMed Citation Articles by Torres, O. A. Articles by Hyland, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LEUCOVORIN Social Bookmarking                         What's this?

Folinic Acid-Responsive Neonatal Seizures

Division of Pediatric Neurology, University of Texas Southwestern Medical Center Dallas, TX

Van S. Miller, MD, PhD

Division of Pediatric Neurology, University of Texas Southwestern Medical Center Dallas, TX

Neil M. R. Buist, MD

Department of Pediatrics, Oregon Health Sciences, University of Oregon Portland, OR

Keith Hyland, PhD

Division of Pediatric Neurology, University of Texas Southwestern Medical Center Dallas, TX, k.hyland{at}baylordallas.edu, Kimberly H. Courtwright and Joseph W Summers Institute of Metabolic Disease Dallas, TX

We report three cases of folinic acid-responsive intractable neonatal seizures. All patients were born at term following normal gestation and delivery. In the first infant, seizures began on the 5th day of life and were unresponsive to phenobarbital, pyridoxine, and valproate, but stopped within 24 hours of initiation of folinic acid treatment at the age of 6 months. Her sibling had died at age 6 months with intractable seizures. In the second infant, seizures began in the 2nd hour of life. These were initially controlled with phenobarbital; however, at 3 months of age she developed status epilepticus refractory to anticonvulsants, steroids, and pyridoxine and she required repeated induction of pentobarbital coma. Seizures stopped within 24 hours of starting folinic acid. Seizures and encephalopathy were noted in the third infant on the 2nd day of life. These were controlled with phenobarbital, but at 8 weeks of age seizures recurred and were difficult to control despite the addition of phenytoin. Immediately after folinic acid was initiated the seizures stopped. Breakthrough seizures in all patients have responded to increases in folinic acid; two of the three remain on standard anticonvulsants. All patients have global developmental delay. Cranial magnetic resonance imaging in the second patient shows diffuse atrophy, and in the third patient shows increased signal on T₂ images in the white matter of the frontal and parietal lobes. Analysis of cerebrospinal fluid from these patients using high-performance liquid chromatography with electrochemical detection has consistently revealed an as-yet unidentified compound, which can be used as a marker for this condition. We suggest that cerebrospinal fluid be analyzed for the presence of this compound and a trial of folinic acid be considered in neonates with unexplained early onset intractable seizures. (J Child Neurol 1999; 14:529-532).

Journal of Child Neurology, Vol. 14, No. 8, 529-532 (1999)
DOI: 10.1177/088307389901400809


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Surtees and N. Wolf Treatable neonatal epilepsy Arch. Dis. Child., August 1, 2007; 92(8): 659 - 661. [Full Text] [PDF]

				R Kneen and R E Appleton Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy Arch. Dis. Child., November 1, 2006; 91(11): 936 - 941. [Abstract] [Full Text] [PDF]

				F.-Y. Lin, G. G. Gascon, K. Hyland, H. Chugani, and D. Chugani Transient Nonketotic Hyperglycinemia and Defective Serotonin Metabolism in a Child With Neonatal Seizures J Child Neurol, October 1, 2006; 21(10): 900 - 903. [Abstract] [PDF]

				J. J. Riviello Jr Pharmacology Review: Drug Therapy for Neonatal Seizures: Part 2 NeoReviews, June 1, 2004; 5(6): e262 - e268. [Full Text] [PDF]

				R. E. Frye, E. Donner, A. Golja, and C. M. Rooney Folinic Acid--Responsive Seizures Presenting as Breakthrough Seizures in a 3-Month-Old Boy J Child Neurol, August 1, 2003; 18(8): 562 - 569. [Abstract] [PDF]

				B. N Ames, I. Elson-Schwab, and E. A Silver High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658. [Abstract] [Full Text] [PDF]

				W. G. Mitchell Status Epilepticus and Acute Serial Seizures in Children J Child Neurol, January 1, 2002; 17(1_suppl): S36 - S43. [Abstract] [PDF]

				K. Hyland and L. A. Arnold Value of Lumbar Puncture in the Diagnosis of Genetic Metabolic Encephalopathies J Child Neurol, November 1, 1999; 14(1_suppl): S9 - S15. [Abstract] [PDF]